Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma

Gynecologic Oncology

Volumn 91, Issue 3, 2003, Pages 558-562

  Lea, Jayanthi S ^a   Coleman, Robert L ^a   Garner, Elizabeth O ^b   Duska, Linda R ^c   Miller, David S ^a   Schorge, John O ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CELL TYPE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; ENDOMETRIUM CARCINOMA; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; METHODOLOGY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOSQUAMOUS; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 1642386743     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.08.020     Document Type: Article

References (19)

1. Smith H.O., Tiffany M.F., Qualls C.R., Key C.R. The rising incidence of adenocarcinomas relative to squamous cell carcinomas of the uterine cervix - a 24-year population based study. Gynecol Oncol. 78:2000;97-105.
2. Berek J.S., Hacker N.F., Fu Y.S., Sokale J.R., Leuchter R.C., Lagasse L.D. Adenocarcinoma of the uterine cervix histologic variables associated with lymph node metastasis and survival. Obstet Gynecol. 65:1985;46-52.
3. Drescher C.W., Hopkins M.P., Roberts J.A. Comparison of the pattern of metastatic spread of squamous cell cancer and adenocarcinoma of the uterine cervix. Gynecol Oncol. 33:1989;340-343.
4. Eifel P.J., Burke T.W., Morris M., Smith T.L. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol. 59:1995;38-44.
5. Hopkins M.P., Morley G.W. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol. 77:1991;912-917.
6. Shingleton H.M., Bell M.C., Fremgen A., Chmiel J.S., Russell A.H., Jones W.H., et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer. 76:1995;1948-1955.
7. Look K.Y., Brunetto V.L., Clarke-Pearson D.L., Averette H.E., Major F.J., Alvarez R.D., Homesley H.D., Zaino R.J. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix a Gynecology Oncology Group study. Gynecol Oncol. 63:1996;304-311.
8. Sedlis A., Bundy B.N., Rotman M.Z., Lentz S.S., Muderspach L.I., Zaino R.J. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy a gynecologic oncology group study. Gynecol Oncol. 73:1999;177-183.
9. Peters W.A. III, Liu P.Y., Barrett R.J. II, Stock R.J., Monk B.J., Berek J.S., Souhami L., Grigsby P., Gordon W. Jr, Alberts D.S. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix. J Clin Oncol. 18:2000;1606-1613.
10. Schorge J.O., Lee K.R., Lee S.J., Flynn C.E., Goodman A.K., Sheets E.E. Early cervical adenocarcinoma selection criteria for radical surgery. Obstet Gynecol. 94:1999;386-390.
11. Benedet J.L., Bender H., Jones H. 3rd, Ngan H.Y., Pecorelli S. FIGO staging classifications and clinical practice guidelines in management of gynecologic cancers. FIGO Committee of Gynecologic Oncology. Int J Gynaecol Obstet. 2:2000;209-262.
12. Cox D.R. Regression models and life tables. J R Stat Soc. 34:1972;187-220.
13. Kaplan E.L., Meier R. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
15. Grisaru D., Covens A., Chapman B., Shaw P., Colgan T., Murphy J., DePetrillo D., Lickrish G., Laframboise S., Rosen B. Does histology influence prognosis in patients with early-stage cervical carcinoma? Cancer. 92:2001;2999-3004.
16. Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P., Favini G., Ferri L., Mangioni C. Randomised study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer. Lancet. 350:1997;535-540.
17. Saigo P.E., Cain J.M., Kim W.S., Gaynor J.J., Johnson K., Lewis J.L. Jr. Prognostic factors in adenocarcinoma of the uterine cervix. Cancer. 57:1986;1584-1593.
18. Matthews C.M., Burke T.W., Tornos C., Eifel P.J., Atkinson E.N., Stringer C.A., Morris M., Silva E.G. Stage I cervical adenocarcinoma prognostic evaluation of surgically treated patients. Gynecol Oncol. 49:1993;19-23.
19. Webb J.C., Key C.R., Qualls C.R., Smith H.O. Population-based study of microinvasive adenocarcinoma of the uterine cervix. Obstet Gynecol. 97:2001;701-706.